Gurugram headquartered healthcare focused firm Flebo.in witnessed a 2.3X rise in its overall revenue in the financial year ending March 2023.
The number spiked to Rs 3.4 crore in FY23 as compared to its preceding fiscal year’s Rs 1.5 crore. Both fiscal’s saw the entirety of the amount being contributed from its sale of services.
Founded by Ajay and Avani Singh, Flebo.in offers home blood collection services to streamline medical testing. Its offerings include Pathology and Radiology test bookings, health package comparisons, data storage, and automatic report analysis among others.
Its expenses shot up almost seven-fold to Rs 17.9 crore in FY23. While advertising and promotional costs contributed about Rs 7 crore to this, employee benefits brought in over Rs 5 crore. Legal charges cost close to Rs 18 lakhs the same year.
Comparatively, Flebo.in’s expenses for FY22 amounted to about Rs 2.6 crore with advertising costs taking up a majority of it.
The three year old startup incurred losses amounting to Rs 10.7 crore in FY23, a 13X rise as compared to FY22’s Rs 80 lakhs. Its current EBITDA margin stands at -424.93% and its ROCE improved to 184.00%.